Newbridge Acquisition Limited (NASDAQ:NBRGU) (the "Company") today announced the execution of the business combination agreement (the "Business Combination Agreement") with Startech Group Inc., an emerging life sciences technology company focused on developing products such as functional water and AI-powered healthcare technologies to enhance human longevity ("Startech").

Pursuant to the Business Combination Agreement, at least one business day prior to the closing date of the business combination, the Company will continue out of the British Virgin Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation by way of continuation (the Company after such domestication, the "Domesticated Company"), Newbridge Merger Sub, Inc., a Delaware corporation ("Merger Sub") and wholly owned subsidiary of the Company, will be merged with and into Startech, resulting in Startech being a wholly owned subsidiary of the Domesticated Company (the "Business Combination" and the transactions in connection with the Business Combination collectively, the "Transaction"). Upon the closing of the Transaction, the parties plan to remain Nasdaq-listed under a new ticker symbol.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.